Comprehensive Cancer Center: Clinical Trials and Research
Stereotactic Body Radiation Therapy (SBRT) in Metastatic Non-small Cell Lung Cancer
Search clinical trials at Wake Forest School of Medicine.
Edward A. Levine, MD, Professor of Surgery, Chief of Surgical Oncology Service, published the first report on genomic analysis of the appendix: Levine EA, Blazer DG, Kim MK, Shen P,Stewart JH, Guy C, Hsu DS. Gene Expression Profiling of Peritoneal Metastases from Appendiceal and Colon Cancer Demonstrates Unique Biologic Signatures and Predicts Patient Outcomes. Journal of the American College of Surgeons 2012; 214:599-607.
Timothy S. Pardee, MD, PhD, Assistant Professor of Hematology and Oncology, has identified a novel chemotherapeutic agent, fluoropyrimidine, FdUMP , that shows efficacy in Acute Myeloid Leukemia cell lines from humans, when tested in the laboratory.
Researcher Michael T. Munley, PhD, looks at correlation between CT scans and cancer risk. Read: Wake Forest Baptist Study Looks at CT Scans, Cancer Risk.
Lead author and researcher Marissa Howard-McNatt, MD, Assistant Professor of Surgery, evaluates why there has been a national trend of women with breast cancer choosing to have both breasts removed even though they only have cancer in one breast. Read: Mastectomy Mystery: Why It's a Choice When Cancer Isn't Evident
Kathryn E. Weaver, PhD, MPH, an Assistant Professor in the Department of Social Sciences and Health Policy, is lead author of a study that found a substantial number of cancer patients continue to smoke after their cancer diagnosis. Read: A Cancer Diagnosis Doesn't Always Mean Patients Quit Smoking.
Read more about Comprehensive Cancer Center Research.